Table 2 Compliance to the salivary sampling protocol
From: Feasibility of home-based sampling of salivary cortisol and cortisone in healthy adults
Total | Baseline | Follow-up | |
|---|---|---|---|
Number of samples, n(%) | |||
1 day in B and FU | 18 (94.74) | 18 (94.74) | 18 (94.74) |
2 days in B and FU* | 18 (94.74) | 18 (94.74) | 18 (94.74) |
3 days in B and FU | 15 (78.95) | 15 (78.95) | 17 (89.47) |
Report sample time, n(%) | |||
1 day in B and FU | 16 (84.21) | 16 (84.21) | 17 (89.47) |
2 days in B and FU* | 16 (84.21) | 16 (84.21) | 16 (84.21) |
3 days B and FU | 10 (52.63) | 13 (68.42) | 12 (63.16) |
Compliant to timing of S1, n(%) | |||
1 day in B and FU | 16 (84.21) | 16 (84.21) | 17 (89.47) |
2 days in B and FU* | 16 (84.21) | 16 (84.21) | 16 (84.21) |
3 days in B and FU | 10 (52.63) | 12 (63.16) | 12 (63.16) |
Compliant to timing of the second and third sample, n(%) | |||
1 day in B and FU | 16 (84.21) | 16 (84.21) | 16 (84.21) |
2 days in B and FU* | 16 (84.21) | 16 (84.21) | 16 (84.21) |
3 days in B and FU | 11 (57.89) | 14 (73.68) | 12 (63.16) |